Joaquin Baruch

Pfizer-BioNTech (BNT162b2) Vaccine Effectiveness against Symptomatic Laboratory-Confirmed COVID-19 Infection among Outpatients in Sentinel Sites, Lebanon, July-December 2021.

Journal: Vaccines

Published: July 01, 2024

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: November 24, 2023

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: November 24, 2023

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.

Journal: Heliyon

Published: September 09, 2023

A multi-country analysis of COVID-19 hospitalizations by vaccination status.

Journal: Med (New York, N.Y.)

Published: April 24, 2023

Hybrid immunity and protection against infection during the Omicron wave in Malta.

Journal: Emerging microbes & infections

Published: December 13, 2022

Liver injury in hospitalized patients with COVID-19: An International observational cohort study.

Journal: PloS one

Published: November 04, 2022

Symptom-based case definitions for COVID-19: Time and geographical variations for detection at hospital admission among 260,000 patients.

Journal: Influenza and other respiratory viruses

Published: June 29, 2022

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.

Journal: International journal of epidemiology

Published: May 31, 2022

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.

Journal: eLife

Published: May 25, 2022

National long COVID impact and risk factors.

Journal: Public health

Published: May 05, 2022

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.

Journal: Scientific data

Published: March 30, 2022

Pfizer-BioNTech (BNT162b2) Vaccine Effectiveness against Symptomatic Laboratory-Confirmed COVID-19 Infection among Outpatients in Sentinel Sites, Lebanon, July-December 2021.

Pfizer-BioNTech (BNT162b2) Vaccine Effectiveness against Symptomatic Laboratory-Confirmed COVID-19 Infection among Outpatients in Sentinel Sites, Lebanon, July-December 2021.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.

A multi-country analysis of COVID-19 hospitalizations by vaccination status.

A multi-country analysis of COVID-19 hospitalizations by vaccination status.

Hybrid immunity and protection against infection during the Omicron wave in Malta.

Hybrid immunity and protection against infection during the Omicron wave in Malta.

Liver injury in hospitalized patients with COVID-19: An International observational cohort study.

Liver injury in hospitalized patients with COVID-19: An International observational cohort study.

Symptom-based case definitions for COVID-19: Time and geographical variations for detection at hospital admission among 260,000 patients.

Symptom-based case definitions for COVID-19: Time and geographical variations for detection at hospital admission among 260,000 patients.

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.

National long COVID impact and risk factors.

National long COVID impact and risk factors.

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.